Colten Bray, NP
Family · Greeley, CONPI 1710585500
Payments from drug & device makers
Across 59 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$274
- Otsuka America Pharmaceutical, Inc.$220
- Astellas Pharma US Inc$177
- Lundbeck LLC$134
- Boehringer Ingelheim$61
- Lilly USA, LLC$59
- plus $260 from 8 others
What the payments were for
- Food & beverage$1,10093%
- Education$857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $274 |
| Otsuka America Pharmaceutical, Inc. | 15 | $220 |
| Astellas Pharma US Inc | 4 | $177 |
| Lundbeck LLC | 7 | $134 |
| Boehringer Ingelheim | 3 | $61 |
| Lilly USA, LLC | 3 | $59 |
| Exact Sciences | 3 | $46 |
| Pfizer | 2 | $43 |
| Johnson & Johnson | 1 | $41 |
| GSK | 2 | $40 |
| Amgen | 2 | $36 |
| Fidia Pharma USA Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Medtronic | 1 | $15 |
How this compares
$1,185 in reported general payments places this provider in the 80th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $1,294 |
| Potassium Chloride | 23 | $1,128 |
| Tamsulosin Hcl | 54 | $667 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $654 |
| Atorvastatin Calcium | 67 | $648 |
| Trazodone Hcl | 35 | $541 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $539 |
| Lisinopril | 80 | $515 |
| Omeprazole | 47 | $506 |
| Levothyroxine Sodium | 64 | $498 |
| Losartan Potassium | 64 | $487 |
| Pregabalin | 20 | $471 |
| Gabapentin | 36 | $430 |
| Amlodipine Besylate | 68 | $429 |
| Rosuvastatin Calcium | 47 | $386 |
Paid to pharmacies, not to this prescriber.
Other family in Greeley
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.